2015
Improvement in vision: a new goal for treatment of hereditary retinal degenerations
Abstract: Introduction: Inherited retinal degenerations (IRDs) have long been considered untreatable and incurable. Recently, one form of early-onset autosomal recessive IRD, Leber congenital amaurosis (LCA) caused by mutations in RPE65 (retinal pigment epithelium-specific protein 65 kDa) gene, has responded with some improvement of vision to gene augmentation therapy and oral retinoid administration. This early success now requires refinement of such therapeutics to fully realize the impact of these major scientific an…
Search citation statements
Paper Sections
Select...
19
6
2
0
Citation Types
0
18
0
0
Year Published
Range
2016
2024
Publication Types
Select...
21
3
2
1
Relationship
1
26
Authors
Journals
Cited by 27 publications
(18 citation statements)
References 77 publications
0
18
0
0
Smart CitationsHow the paper below cites the one you are viewing
“…For the same reason, even the use of fixed reference values of total retinal thickness, such as the thickness of the central subfield >100 μm considered for patients eligible for Luxturna therapy, should not be considered unequivocal proof of the presence of photoreceptors [ 27 ] but should always be used to assess their functionality. In fact, experimental evidence shows that degeneration can proceed even after patients have been treated, suggesting that there has been a certain threshold of photoreceptor loss in these patients [ 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 ]. For this reason, the loss of approximately 30% of the normal complement of photoreceptors is a therapeutic prerequisite with Luxturna, a threshold beyond which treatment will not have the desired outcome, with the progression of retinal degeneration occurring [ 33 , 59 ].…”
Section: Discussion
mentioning
confidence: 99%
Abstract